HC Wainwright Predicts Stronger Earnings for Legend Biotech

Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Equities researchers at HC Wainwright increased their Q1 2025 EPS estimates for Legend Biotech in a report issued on Wednesday, March 12th. HC Wainwright analyst M. Kapoor now expects that the company will post earnings of ($0.18) per share for the quarter, up from their prior estimate […]

Leave a Reply

Your email address will not be published.

Previous post Roth Capital Estimates Fathom’s Q1 Earnings (NASDAQ:FTHM)
Next post Q1 EPS Estimates for EPAM Systems Lowered by Zacks Research